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Abstract 
Background: The literature data on malaria in Western Kasai, DRC, are limited and inadequate. A recent molecular 
survey there has detected Plasmodium ovale and Plasmodium malariae as mixed infections with Plasmodium falcipa-
rum. In Tshimbulu, Western Kasai, during a humanitarian initiative designed to provide children with free preventive 
screening and to reduce the local high malaria death rate, accurate species identification was performed, in order to 
collect unambiguous epidemiological data and to evaluate the reliability of locally applied diagnostics.
Methods: Finger pricks provided fresh blood for microscopic analysis (MA), for rapid diagnostic test (RDT) and for 
molecular diagnostics (MD). MA and RDT were first performed by the local team and then a re-interpretation of the 
results (on the same slides and on RDT’s taken pictures) was conducted in Italy, where MD were performed.
Results: The analysis was conducted on 306 children; RDT found 80.9 % as P. falciparum-positive (37.4 % as two-band 
positive, P. falciparum single infection). MA identified a further four children as positive to P. falciparum and six co-
infections with P. ovale. The second RDT evaluation confirmed a similar infection rate (78.2 %) but interpreted as two-
band positive a significantly higher share of tests (56.8 %). MA confirmed 80.0 % of the children as malaria positive 
and, in addition to P. falciparum, identified P. malariae (13.8 %), P. vivax (3.4 %) and P. ovale (2.4 %), and detected Babesia 
microti in 19 smears. MD confirmed all of the species found (Babesia microti included), classified as mono-infection 
with P. falciparum a rate of spots comparable to MA revision, and identified all P. ovale as Plasmodium ovale wallikeri. 
The RDT used locally proved 93.1 % sensitive and 92.1 % specific for P. falciparum.
Conclusions: The malaria prevalence among the children and the presence of four Plasmodium species, highlighted 
in this study, identified a sanitary issue which proved to be more alarming than expected, as it was worsened by the 
unpredictable presence of P. vivax and Babesia microti (never before reported in DRC). Each diagnostic tool showed its 
point of weakness. Therefore, the most correct approach is by the combined use of different, locally available, diag-
nostic tools.
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Background
In the Democratic Republic of Congo (DRC) the Ministry 
of Health reports malaria as the main cause of morbid-
ity and mortality, mainly affecting pregnant women and 
children under 5 years of age. #is disease accounts for 
more than 40 % of all outpatient visits and for 40 % of 
deaths in children <5 years of age, as they are often hospi-
talized when their anaemia is too severe [1].
Despite the high impact of the disease, the epidemio-
logical data are inadequate, as they mostly derive from 
local studies that do not allow for national estimates. 
Only the 2007 demographic data and 2013–2014 health 
surveys showed that 33.5 % of women and 34.1 % of chil-
dren aged six to 59 months were positive in molecular 
testing [2, 3].
#e species mainly represented were Plasmodium fal-
ciparum (95 % of infections), followed by Plasmodium 
malariae (4.9  %) and Plasmodium ovale (0.6  %) [4]. 
Appropriate laboratory tools are critical for a prompt 
diagnosis and treatment of the infection, especially in 
light of the increasing detection of resistance to drugs in 
many areas of the world [5, 6].
Existing diagnostics include microscopic analysis 
(MA) of blood (stained in thin and thick films), immu-
nological rapid diagnostic test (RDT) and molecular 
diagnostics (MD). MA represents the ‘gold standard’ for 
malaria identification and species determination in many 
endemic areas as it is relatively inexpensive, locally acces-
sible and the only diagnostic providing parasite count-
ing (parasitaemia). However, several challenges exist 
in performing MA for routine clinical use, especially in 
endemic countries where urgency is pressing, infrastruc-
tures may be obsolete, and resources are often limited, 
such as availability of well-trained microscopists. In this 
scenario misdiagnosis due to low parasitaemia or mixed 
infections is likely to occur [7]. Additionally, MA may 
not accurately identify all species [8], as in the case of 
Plasmodium knowlesi, which for a long time was falsely 
diagnosed as P. malariae and later correctly identified in 
humans only through the use of MD [9]. #erefore, espe-
cially in limited resource settings, RDT replaces or sup-
ports MA, as it rapidly detects parasite antigens and is 
easy to use.
Good quality RDT is generally as sensitive as MA in 
detecting P. falciparum (about 100 parasites/µL), whereas 
it is much less sensitive in identifying other species, and 
does not determine the parasitic burden [10]. Moreover, 
RDT can result in false positive up to one month after 
clearance of parasites, and interference due to presence 
of heterophile antibodies in patients’ samples has been 
reported [10].
As far as MD is concerned, while being useful to iden-
tify parasite species, to detect low parasitaemia [11] and 
mixed infections [12], it is expensive, requires equipped 
laboratories with skilled technicians, does not provide 
immediate results, and therefore is not suitable for rou-
tine diagnosis; its appropriate use is restricted to the 
research field.
All these diagnostic tools were applied during a two-
step malaria survey. #e first step was carried out during 
a humanitarian action conducted by LB who was working 
with the laboratory team of the Saint François Hospital 
in the town of Tshimbulu (Western Kasai, rural area of 
DRC).
In this area of Western Kasai, despite all the therapy 
and interventions, a high death rate both from anaemia 
and malaria, diagnosed in a limited resource setting, 
is still registered. A complete and definitive picture of 
Plasmodium species affecting this population would be 
necessary and crucial for local public health and epide-
miology. To achieve these goals, LB organized a local task 
force (including three laboratory technicians, two nurses 
and a local facilitator, together with a volunteer group of 
mothers) to design and conduct the screening.
#e second step was possible due to a scientific, non-
profit-making collaboration between the team in loco 
operative and Italian researchers, in order: (1) to submit 
a large number of children to a preventive screening for 
malaria, followed by therapy if necessary; (2) to collect 
detailed epidemiological data, identifying Plasmodium 
species present in Tshimbulu; and (3) to evaluate the 
appropriateness of assays usually applied to diagnose 
malaria in local hospitals, where a high number of pyretic 
and/or anaemic children are often waiting for a diagnosis.
Methods
Study area and population
#e large town of Tshimbulu (6°29′0″S; 22°51′0″E, Lulua 
rural district, province of Western Kasai), nestled in the 
savannah, covers an area of about 10 sq km. #e health 
system in Tshimbulu is part of Dibaya health area, com-
prising 17 health centres, one hospital of reference and 
the Saint François Hospital (Catholic Archidiocese of 
Kananga-owned), which has a catchment area of about 
499,000 people. #e population lives below subsistence 
level. #ere is neither productive activity, nor public 
energy or water. Householders own insecticide-treated 
bed nets as the only malaria control measure, but these 
are often improperly used.
Study design
In October 2014 the whole community was alerted by 
local rural radio, organizations and through notice given 
in churches and markets that a free malaria screen-
ing, aimed at preventing the deaths from the infec-
tion, was offered to all children under 5 years old. #is 
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humanitarian initiative was started in collaboration with 
the Managing Director and staff of the Saint François 
Hospital. #e hospital is an essential part of the Ministry 
of Health, which sustained the costs related to diagnostic 
RDT and drugs, and gave ethical approval. All mothers 
provided informed consent for their children. Many of 
them helped by involving more mothers and actively took 
part in any decision about their children’s treatments, 
hospitalization and/or therapy administration [artemes-
inin combination therapy (ACT)] according to national 
guidelines based on Malaria Operational Plan Fy 2013 
(http://www.pmi.gov).
All subjects were examined clinically and axillary tem-
peratures were recorded. Fresh blood was obtained by 
pricking a child’s finger, and standard malaria thick and 
thin smears were prepared and stained with 10 % Giemsa 
solution, following the method described in the WHO 
Malaria Microscopy Guide (http://apps.who.int). A fur-
ther 5 µL of blood were used to perform RDT (Standard 
Diagnostic Inc., Bio Line Malaria Ag Pf/Pan Rapid Test, 
Cat. No. 05FK60) and, starting from the fifth day, two 
drops of blood were drawn and used to impregnate a fil-
ter paper for MD.
#e help of each mother and of a facilitator speaking 
the local dialect allowed completion of a form about 
each baby (sex, age, fever attacks, drugs taken, previous 
malaria attacks), with data on anaemia, fever and course 
of the infection during therapy.
RDT was locally performed according to manufac-
turer’s instructions (RDT1), and serially numbered. 
Each of them was read and then photographed within 
15–30 min, all in the same place, position and lighting 
conditions, controlling the match between each image 
and the related device test. In this way pictures were 
available for both a second interpretation (RDT2) and for 
the final comparison of the findings obtained by means of 
the three methods.
Giemsa-stained smears were locally examined (triple 
blinded) by microscopy at 100× in the hospital labo-
ratory (MA1). A whole thick smear was read before 
declaring a slide negative. Parasite density was estimated 
by means of the Plus system, and species identification 
was confirmed on the corresponding thin film. A further 
(double) blinded microscopic analysis on 290 undamaged 
available slides was carried out in Italy to evaluate the 
level of accordance of the results (MA2).
Molecular analyses
DNA was extracted from a 3 × 3 mm diameter circle of 
each of the 211 dried blood spots using the commercial 
kit Dried Blood spot DNA isolation Kit (Norgen Biotek 
Corp, Ontario, Canada) and following manufacturer’s 
instructions. In some cases a further DNA extraction was 
necessary from additional paper circles.
As previously described for diagnosing Plasmodium 
species in human blood samples [13], a Plasmodium 
spp. rRNA gene fragment (ssrRNA 18S) of about 250-
bp was amplified. #en a P. falciparum, P. malariae, P. 
ovale, and Plasmodium vivax species-specific PCR pro-
tocol was employed on all genus-specific PCR positive 
samples, with primers and thermal profiles described 
in Table 1, to amplify fragments of about 276, 412, 375, 
300  bp, respectively. An amplification control based 
on the human beta-actin gene was performed in paral-
lel to monitor PCR inhibition and to control for DNA 
integrity. PCR amplification was performed in a final 
volume of 25 μL under the following conditions: 10× 
buffer including 1.5 mM MgCl2, 0.2 mM of each dNTP, 
1 unit of DNA polymerase (BIOTAQ™ DNA Polymer-
ase, Aurogene, Rome, Italy) and 5 μL of template. #e 
primer concentrations were 15  pmol of P. falciparum, 
17.5 pmol of P. ovale and P. malariae, and 7.5 pmol of 
P. vivax forward.
To test the specificity of the reaction, 5 μL of DNA 
extracted from blood samples microscopically positive 
for Plasmodium were included in each PCR run as posi-
tive control, whereas 5 μL of double-distilled water was 
employed as negative control. Amplicons were purified 
using the SureClean kit (Aurogene, Rome, Italy) follow-
ing manufacturer’s instructions, and were then directly 
Table 1 Primer sets and PCR conditions for DNA ampli"cation of Plasmodium species
Plasmodium species Primers Product  
size (bp)
PCR conditions
Plasmodium spp. PgMt19F3 5′-TCG CTT CTA ACG GTG AAC-3′
PgMt19B3 5′-AAT TGA TAG TAT CAG CTA TCC ATA G-3′
250 95 °C, 15′; 5 cycles [95 °C 10″, 62 °C 30″, 72 °C 15″]; 45 
cycles [95 °C 10″, 62 °C 10″, 72 °C 15″] 72 °C, 10′
P. falciparum forward 5′-AAC AGA CGG GTA GTC ATG ATT GAG-3′ 276 95 °C, 15′; 43 cycles [95 °C 45″, 60 °C 90″, 72 °C 45″]; 
72 °C, 10′P. malariae forward 5′-CGT TAA GAA TAA ACG CCA AGC G-3′ 412
P. ovale forward 5′-CTG TTC TTT GCA TTC CTT ATG C-3′ 375
P. vivax forward 5′-CGG CTT GGA AGT CCT TGT-3′ 300
Species-specific reverse 5′-GTA TCT GAT CGT CTT CAC TCC C-3′
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sequenced with PCR primers in both directions by an 
external sequencing core service (Eurofins Genomics, 
Anzinger, Germany). #e resulting chromatograms were 
analysed and edited. #e obtained sequences were com-
pared to those from Plasmodium deposited in GenBank™ 
and available at the website: http://www.ncbi.nlm.nih.gov 
by using the BLAST application, and aligned using the 
software CLUSTAL X (www.clustal.org) for comparative 
analysis. In addition, having the MA2 detect the pres-
ence of Babesia spp. in several blood samples, the corre-
sponding DNA were further amplified using the primers 
CRYPTO F (5′-AACCTGGTTGATCCTGCCAGT-3′) 
and RLB-R2 (5′-CTA AGA ATT TCA CCT CTG ACA 
GT-3′), which amplify a fragment of approximately 
800 bp of the piroplasm 18S ribosomal RNA, using the 
previously described protocol [14]. Amplicons were then 
sequenced and aligned as above.
Statistical analyses
Different frequency distributions were evaluated by 
means of the χ2 test, and p values <0.05 were considered 
significant. Cohen’s K index was calculated to evaluate 
the concordance between the results obtained, for each 
sample, by each considered diagnostic.
Results
In the last 14 days of November 2014, a total of 306 chil-
dren were screened for malaria. #ey were aged from 
1 week to <5 years (median age =  29.7 months, ratio 
male/female = 1.15).
Prevalence evidenced by each applied method is 
reported in Table 2 and Fig. 1, while Table 3 summarizes 
species identification.
#e immediate diagnosis by means of the RDT failed 
in 12/306 analyses (3.9 %) and 80.9 % (95 % CI 76.5–85.5) 
of the children were classified as positive to P. falcipa-
rum (37.4 and 62.6 % of which were two-band and three-
band positive, respectively) (Table 2; Fig. 1, line RDT1).
#e local laboratory team rectified by MA a total of 
four negative RDT tests into positive with very low para-
sitaemia due to P. falciparum, suspected the co-presence 
of P. ovale in six smears (2.0 %) (Tables 2, 3; Fig. 1, line 
MA1), and evaluated the parasitic burden valid for clas-
sification slides (n  =  298), so establishing an overall 
malaria prevalence of 81.2 % (CI 76.8–85.6). #e differ-
ence in the overall infection rate highlighted by the two 
diagnostic tools was not significant (p =  0.937), and K 
index confirmed their excellent overall concordance 
(K = 0.83).
#e revision of the RDT results classified 5 % of the 298 
available tests as unsuccessful (a picture of seven results 
was lost) and identified 222/284 infected children. #ere-
fore, the overall prevalence of P. falciparum antigens 
became 78.2 % (95 % CI 73.4–83.0), a result which proved 
to be no statistically different from the one obtained in 
loco (p = 0.406), although this revision revealed 56.7 and 
Table 2 Prevalence of malaria and of mono-infections (1sp) detected by rapid test (RDT1 and RDT2), microscopic analysis 
(MA1 and MA2) and molecular diagnostics (MD) applied to children living in Tshimbulu (Western Kasai, DRC), and p val-
ues obtained by comparing the di#erent results
Pos/ex (%)
RDT1 MA1 MA1 1sp RDT2 MA2 MA2 1sp MD MD 1sp
(80.9) (81.2) (79.2) (78.2) (80.0) (54.8) (82.8) (73.7)
RDT1 0.937 0.406
 238/294
MA1 0.937 0.711 0.734
 242/298
MA1 1sp <0.0001 0.157
 236/298
RDT2 0.406 0.589
 222/284
MA2 0.711 0.589 0.505
 232/290
MA2 1sp <0.0001 <0.0001
 159/290
MD 0.734 0.505
 164/198
MD 1sp 0.157 <0.0001
 146/198
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43.2 % of infected children as two-band and three-band 
positive, respectively (Fig.  1, line RDT2): a significantly 
different interpretation (p < 0.0001).
#e revision by MA of available thick and thin smears 
(Tables 2 and 3, and Fig. 1, line MA2), classified 58/290 
children as negative (20.0 %; CI 15.4–24.6) and identi-
fied 158 (54.5 %; CI 49.2–59.7) as affected by P. falcipa-
rum, one patient by P. vivax (0.3 %) and 73 (25.2 %; CI 
62.9–83.1) with mixed infection, for an overall infection 
rate of 80.0 % (CI 75.4–84.6), not statistically different 
from MA1 and RDT2 results (p = 0.711 and p = 0.589, 
respectively). However, on a quality level, MA2 identi-
fied P. falciparum as the most prevalent species (79.7 %; 
CI 75.0–85.0), followed by P. malariae (13.79 %; CI 9.8–
17.8), P. vivax (3.4 %; CI 1.4–5.4), and P. ovale (2.4 %; CI 
0.6–4.2).
Plasmodium falciparum was mostly detected as single 
infection, whereas P. malariae and P. ovale were always 
combined with P. falciparum (in 16.4 and 2.6 % of the 
infections, respectively) and, in one case, as a triple infec-
tion. As for P. vivax, this species was identified as single 
(n = 1) and mixed infection (with P. falciparum and triple 
infection with P. malariae). Furthermore, the revision of 
the slides evidenced the presence of Babesia microti in 19 
smears, always associated to P. falciparum and classified, 
by RDT, as P. falciparum two-band (n = 12) and three-
band (n = 6) infection, and ‘invalid test’ (n = 1) (Table 3, 
line MA2).
Fig. 1 Malaria results obtained by rapid diagnostic test (RDT1 and RDT2: two-band and three-band positive), microscopic analysis (MA1 and MA2) 
and molecular diagnostics (MD) applied to blood samples of children living in Tshimbulu (Western Kasai, DRC). Pf = P. falciparum; Pv = P. vivax; 
Mixed = ≥2 Plasmodium species
Table 3 Plasmodium species and  their absolute (%) 
and  relative prevalence (R  %) identi"ed by  microscopic 
analyses (MA1 and MA2) and molecular diagnostics (MD) 
applied to blood samples of  children living in Tshimbulu 
(Western Kasai, DRC) (P.f. = P. falciparum; P.m. = P. malar-
iae; P.o. = P. ovale; P.v. = P. vivax)
Species No. (%; relative %)
MA1 MA2 MD
No. valid for classifica-
tion
298 290 198
Negative 56 58 34
P.f. 236 (79.2; 97.5) 158 (54.5; 68.1) 146 (73.7; 89.0)
P.v. 0 1 (0.3; 0.4) 0
P.f. + P.m. 0 38 (13.1; 16.4) 13 (6.6; 7.9)
P.f + P.o. 6 (2.0; 2.5) 6 (2.1; 2.6) 2 (1.0; 1.2)
P.f. + P.v. 0 8 (2.8; 3.4) 1 (0.5; 0.6)
P.f. + P.m. + P.o. 0 1 (0.3; 0.4) 0
P.f. + P.m. + P.v. 0 1 (0.3; 0.4) 1 (0.5; 0.6)
P.f. + B. microti 0 19 (6.6; 8.2) 2 (1; 1.2)
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#e prevalence of mono-infections with P. falciparum 
(54.5  %) identified by second slide examination (MA2) 
was significantly different from that evidenced by MA1 
(79.2 %; p  <  0.0001), as confirmed by the poor overall 
concordance (K  =  0.08) observed between the results 
on the available comparable specimen. As expected, 
MD detected the highest number of infections: 164/198 
(82.8  %; CI 80.3–85.7) children proved to be positive 
(Tables  2 and 3, and Fig.  1, line MD). In addition, MD 
confirmed the MA2 identification of P. malariae, P. ovale 
and P. vivax only in 13, two, two of the 198 available dried 
filters, respectively, and the presence of Babesia microti in 
only two of them (Table 3, line MD). Sequencing allowed 
the classification of the found P. ovale as Plasmodium 
ovale wallikeri.
#e overall prevalence of single infections with P. fal-
ciparum identified by MD (73.7 %) is significantly differ-
ent (p < 0.0001) only from that detected by MA2 (54.5 %). 
However, considering the results of MA2 concerning 
only 164 children positive to MD, the difference in preva-
lence of mono-infection with P. falciparum is withdrawn: 
the concordance between the two diagnostics was excel-
lent (K = 0.84).
Finally, Fig.  2 shows the molecular identification of 
Plasmodium species present in samples classified by 
RDT1 as two-band and three-band positive. With the 
exception of 4  % of the samples, which had initially 
been read  as positive, two-band positive results were 
also caused by mixed infections with P. vivax and Babe-
sia microti, whereas three-band positive by those with 
P.vivax, P. ovale and P. malariae.
With MD as the gold standard, and considering only 
the 198 subjects tested in loco with all the diagnostic 
tools, sensitivity and specificity of the tests in loco per-
formed in detecting malaria due to P. falciparum were 
93.1 and 92.1  % (RDT1), and 93.2 and 100  % (MA1), 
respectively.
Discussion
Epidemiological data on malaria in Western Kasai, DRC, 
are limited and inadequate, despite this country is suffer-
ing the second-highest burden of malaria globally [2]; the 
infrastructure to undertake complex surveillance pro-
grammes for a reproducible and efficient surveillance are 
very poor. #is initiative carried out on 306 children pro-
duced alarming results: more than 80 % were affected by 
severe malaria (as suggested by haemoglobin (Hb) meas-
urements performed at the time of testing), and also due 
to the unexpected species P. vivax. Moreover, and for the 
first time in DRC, human infections with the zoonotic 
Babesia microti, which may contribute to anaemia, were 
detected.
Comparing the present findings with available data, 
malaria prevalence (82.8  %) evidenced by MD in chil-
dren of Tshimbulu pointed out a sanitary problem which 
turned out to be more alarming (43.7 %) than reported 
by molecular studies on malaria epidemiology in West-
ern Kasai [3] and, in general, in DRC (33.5 %, 34.1 %) [2, 
3]. Furthermore, the presence of P. malariae and P. ovale 
(with relative prevalence 8.5 and 1.2 %) was confirmed 
and the additional presence of P. vivax was evidenced. 
In the studied area, where the lack of the Duffy antigen 
is widespread, the existence, although at very low preva-
lence (1.2  %), of this unexpected Plasmodium species 
should draw attention to the possible clinical and epide-
miological consequences. Indeed, it is well known that: i) 
P. vivax gametocytes are produced earlier than those of P. 
falciparum [15], and are transmissible to Anopheles mos-
quito vectors at lower parasite densities than those of P. 
falciparum, and more efficiently [16]; therefore, transmis-
sion before diagnosis or treatment may occur [17]; ii) it is 
often the ‘last parasite standing’ following P. falciparum 
elimination [18, 19]; and, iii) as P. falciparum, this species 
is resistant to chloroquine [5]. #at is: all the biological 
features of P. vivax make it necessary to be aware of its 
geographical distribution in order to plan appropriate 
control measures, aside from applying a suitable therapy 
to infected subjects.
Notwithstanding these relevant findings, the accu-
racy of diagnoses performed in the limited resource 
setting of DRC and, then in a research laboratory, was 
not entirely satisfactory. Indeed, considering that MD 
was not applied to 106 samples (93 not collected plus 13 
not suitable dried spots), and, therefore, in these cases 
the three methodologies could not be compared, analy-
sis of the results obtained by means of RDT, MA of the 
blood and MD, suggests the following observations. In 
respect of overall infection rates, RDT1 and MA1 results 
were in greater agreement with MD than RDT2 and 
MA2 findings that, however, were not significantly dif-
ferent from MD (Table  2). On the contrary, when the 
Fig. 2 Molecular identification of Plasmodium species present in 
samples classified by RDT1 as two-band (left) and three-band (right) 
positive
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results are analysed in detail, only MA2 is in agreement 
with MD: there are four Plasmodium species affecting 
children in Tshimbulu, and Babesia microti is present, 
even if all of them are in low percentages, which means 
in loco performed analyses are satisfactory in detecting 
infection, but not as satisfactory as identifying the spe-
cies involved.
However, each diagnostic tool used in loco and then, in 
a research laboratory during the revision of the pictures 
of RDT, smears and dried filter papers from Tshimbulu, 
confirmed the intrinsic bias, which may explain the con-
trasting results.
Locally applied RDT demonstrated its usefulness for 
rapid diagnosis of malaria; however, it is useful to note 
that at least 1.9 % of infections remained undiagnosed, 
and Pan weak bands were exposed to doubtful inter-
pretation, probably due to partial corruption during 
transportation (it is known that test line intensity may 
decrease with either parasite density and exposure to 
>70 % humidity and/or >30  °C). #erefore, in respect of 
the performance assured (for P. falciparum: sensitivity 
99.7 % and specificity 99.5 %), the employed RDT proved 
to be less sensitive and specific. Moreover, as expected 
(data sheet informs that three-band positive sample do 
not means mixed infection), it did not allow identifica-
tion of mixed infections and, even less so, the species 
involved in infections, data very important for possible 
relapses due to the presence of P. vivax and P. ovale and 
for possible renal damage induced by P. malariae. Con-
sidering the additional well-known criticism about the 
inability to evaluate parasitic load, which is essential to 
define the severity of the infection, the immediate meas-
ures necessary, and the treatment efficiency, RDT cannot 
be the only employed method.
Regarding MA, the present findings demonstrate its 
high performance in detecting all Plasmodium species 
present only when carried out by well-trained micros-
copists in a laboratory setting. Otherwise, when a high 
number of children are awaiting diagnosis, important 
detail of infections (such as mixed infections) may be 
overlooked or not recognized. #e lower (not signifi-
cant) sensitivity shown by MA2 (80.0  %) when com-
pared to MD (82.8  %), accepting as a true result the 
presence of 15 microscopically negative smears (as con-
firmed by negative RDT) in the first group of children 
unexamined by MD, becomes less relevant, and totally 
overlaps the results from children examined by both 
diagnostics (100  % sensitivity). #e same applies for 
mixed infections: several mixed infections detected by 
MA2 in the first 100 children may have been lost by the 
unapplied MD, so that the prevalence of mono-infec-
tions with P. falciparum stated by MD is only appar-
ently higher than that identified by MA2, as confirmed 
by the excellent concordance (K  =  0.86) about sim-
ple and mixed infections observed on the remain-
ing 164 children proved positive to both diagnostics. 
However, results obtained by this method sometimes 
proved to be uncorrected. In detail, co-infections of P. 
falciparum with P. malariae diagnosed during the revi-
sion of the slides proved overestimated, may be due to 
a misidentification of P. falciparum in cases of severe 
malaria (the data on corresponding children reported a 
very low Hb concentration). Indeed, due to P. falcipa-
rum cyto-adherence, in these cases peripheral blood 
included trophozoites developed further than usual lit-
tle rings: they are very alike P. malariae and infection 
may be identified as co-infection. #is pitfall has been 
overcome during MA1 because the local team, who fre-
quently identify severe malaria, is probably used to rec-
ognizing P. falciparum in these conditions. #e second 
(possibly in the absence of corresponding MD identifi-
cation) misdiagnosis of MA2 (namely some P. falcipa-
rum interpreted as P. vivax/ovale) occurred in cases of 
macrocytic anaemia and when slides were badly stained, 
which make it reasonable that there was an absence of 
evident Schüffner’s granulations: some single infec-
tion with P. falciparum may have been read as possible 
mixed infection. Finally, Babesia microti has been over 
identified, probably as it is very similar to P. falciparum 
when just entered in the erythrocyte. In these circum-
stances, as well as to distinguish the two major forms 
of P. ovale, parasite morphology proved unsuitable for 
a systematic analysis of the relationship between the 
different species and only PCR-based methods proved 
to be reliable. However, in this study several under-
estimated mixed infections diagnosed by MD were 
observed. It could be strictly linked to the difficulties in 
extracting DNA from the dried blood spots and, conse-
quently, to the possibility of identifying only the most 
abundant species. #erefore, MD may present weak 
spots that affect its performance.
As for the comparison of the performance shown by the 
applied malaria tests, the higher (however in this case not 
significant) sensitivity of MD in respect to MA and RDT, and 
the ~90 % specificity of the RDT used, reported in previous 
studies [3, 20] were confirmed. However, in this experience it 
is crucial to underline the ability of the local team in detect-
ing positive slides (81.2 % instead of 82.8 %), higher than that 
reported in the abovementioned paper (22.7 vs 34.1 %) [20].
Conclusions
#e findings in Tshimbulu pointed out worrying malaria 
prevalence in children, mostly without symptoms of the 
disease, due to four Plasmodium species. In addition, the 
zoonotic Babesia microti, which may contribute to their 
anaemia, was detected.
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As for the accuracy of in loco applied diagnostic 
tools, if a rapid replay of a clinical suspicion is very 
useful, the importance of both easy interpretation of 
the test and the identification of mixed infections can-
not be underestimated. The RDT used, like most RDT, 
is exposed to doubtful interpretation and is unable to 
offer important detail of an infection, therefore, the 
production of devices that recognize all species, P. 
knowlesi included, and characterize mixed infections 
should be promoted.
#is experience highlighted a satisfactory level of 
competence in a rural hospital laboratory team in evi-
dencing positive children, but several difficulties in iden-
tifying Plasmodium species, which is a major issue for 
all microscopists in any diagnostic setting. #is difficulty 
may be overcome by improving the current practice of 
microscopy through the use of available on-loan sets of 
thick and thin malaria smears, self-testing for compe-
tency in malaria microscopy [21], and newer and more 
sophisticated assays and technical platforms, such as that 
used by the local team: a m-phone practical training [22].
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